Comerica Bank
TVTX icon

Comerica Bank’s Travere Therapeutics TVTX Stock Holding History

Comerica Bank’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$43K Buy
1,127
+492
+77% +$16K ﹤0.01% 2907
2025
Q3 		$15.2K Buy
635
+243
+62% +$4.57K ﹤0.01% 3160
2025
Q2 		$5.81K Sell
392
-272
-41% -$4.51K ﹤0.01% 3342
2025
Q1 		$11.9K Sell
664
-372
-36% -$7.55K ﹤0.01% 3139
2024
Q4 		$18.1K Sell
1,036
-550
-35% -$9.73K ﹤0.01% 3059
2024
Q3 		$22.2K Buy
1,586
+1,117
+238% +$11.6K ﹤0.01% 3015
2024
Q2 		$3.86K Hold
469
– – ﹤0.01% 3355
2024
Q1 		$3.62K Sell
469
-152
-24% -$1.28K ﹤0.01% 3406
2023
Q4 		$5.58K Buy
621
+258
+71% +$1.88K ﹤0.01% 3288
2023
Q3 		$3.25K Buy
+363
New +$5.12K ﹤0.01% 3472

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Comerica Bank's TVTX Position: Q4 2025 in Review

Comerica Bank increased its Travere Therapeutics (TVTX) stake by 77% in Q4 2025, buying an estimated $16K and bringing the position to 1,127 shares worth $43K. The position accounts for ﹤0.01% of the portfolio, ranked #2907.

Comerica Bank first reported a position in TVTX in Q3 2023 and has held it in 10 quarters since. 278 funds tracked by Wall St. Rank hold TVTX as of Q4 2025.

  • Comerica Bank held 1,127 shares of Travere Therapeutics worth $43K as of Q4 2025.
  • Comerica Bank bought 492 Travere Therapeutics shares in Q4 2025, an estimated $16K.
  • Travere Therapeutics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2907 holding.
  • Comerica Bank first reported a position in Travere Therapeutics in Q3 2023 and has held it in 10 quarters since.
  • 278 funds tracked by Wall St. Rank held Travere Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.